PharmChem Gross Profit vs. Number Of Employees

PCHM Stock  USD 3.05  0.00  0.00%   
Taking into consideration PharmChem's profitability measurements, PharmChem may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess PharmChem's ability to earn profits and add value for shareholders.
For PharmChem profitability analysis, we use financial ratios and fundamental drivers that measure the ability of PharmChem to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well PharmChem utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between PharmChem's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of PharmChem over time as well as its relative position and ranking within its peers.
  
Check out Your Equity Center.
Please note, there is a significant difference between PharmChem's value and its price as these two are different measures arrived at by different means. Investors typically determine if PharmChem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PharmChem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

PharmChem Number Of Employees vs. Gross Profit Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining PharmChem's current stock value. Our valuation model uses many indicators to compare PharmChem value to that of its competitors to determine the firm's financial worth.
PharmChem is rated below average in gross profit category among its peers. It also is rated below average in number of employees category among its peers . The ratio of Gross Profit to Number Of Employees for PharmChem is about  532,909 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the PharmChem's earnings, one of the primary drivers of an investment's value.

PharmChem Number Of Employees vs. Gross Profit

Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.

PharmChem

Gross Profit

 = 

Revenue

-

Cost of Revenue

 = 
5.86 M
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.

PharmChem

Number of Employees

 = 

Full Time

+

Part Time

 = 
11
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.

PharmChem Number Of Employees vs Competition

PharmChem is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 107,901. PharmChem adds roughly 11.0 in number of employees claiming only tiny portion of equities under Health Care industry.

PharmChem Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in PharmChem, profitability is also one of the essential criteria for including it into their portfolios because, without profit, PharmChem will eventually generate negative long term returns. The profitability progress is the general direction of PharmChem's change in net profit over the period of time. It can combine multiple indicators of PharmChem, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
PharmChem, Inc. provides PharmChek Sweat Patch that is used to detect drugs of abuse. Its PharmChek Sweat Patch uses sweat as the source and offers alternative to urine testing for cocaine, opiates, amphetamines, PCP, and marijuana. Pharmchem is traded on OTC Exchange in the United States.

PharmChem Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on PharmChem. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of PharmChem position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the PharmChem's important profitability drivers and their relationship over time.

Use PharmChem in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if PharmChem position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PharmChem will appreciate offsetting losses from the drop in the long position's value.

PharmChem Pair Trading

PharmChem Pair Trading Analysis

The ability to find closely correlated positions to PharmChem could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace PharmChem when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back PharmChem - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling PharmChem to buy it.
The correlation of PharmChem is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as PharmChem moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if PharmChem moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for PharmChem can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your PharmChem position

In addition to having PharmChem in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Russia On Wall Street Thematic Idea Now

Russia On Wall Street
Russia On Wall Street Theme
Cross-sector and cross-instrument bundle of publicly traded Russian entities that are expected to be listed on USA exchanges or over the counter. The Russia On Wall Street theme has 23 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Russia On Wall Street Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in PharmChem Pink Sheet

To fully project PharmChem's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of PharmChem at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include PharmChem's income statement, its balance sheet, and the statement of cash flows.
Potential PharmChem investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although PharmChem investors may work on each financial statement separately, they are all related. The changes in PharmChem's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on PharmChem's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.